森下仁丹の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/27 | 1,960 | 2,042 | 1,960 | 2,030 | +71 | +3.6% | 2,100 |
2020/03/26 | 1,984 | 1,995 | 1,954 | 1,959 | ±0 | ±0% | 3,300 |
2020/03/25 | 1,920 | 1,960 | 1,920 | 1,959 | +76 | +4% | 3,300 |
2020/03/24 | 1,925 | 1,929 | 1,865 | 1,883 | +17 | +0.9% | 1,200 |
2020/03/23 | 1,770 | 1,883 | 1,770 | 1,866 | +106 | +6% | 3,000 |
2020/03/19 | 1,800 | 1,820 | 1,760 | 1,760 | -11 | -0.6% | 1,500 |
2020/03/18 | 1,767 | 1,807 | 1,739 | 1,771 | +44 | +2.5% | 1,400 |
2020/03/17 | 1,701 | 1,727 | 1,670 | 1,727 | +26 | +1.5% | 1,900 |
2020/03/16 | 1,680 | 1,765 | 1,680 | 1,701 | +29 | +1.7% | 2,800 |
2020/03/13 | 1,760 | 1,760 | 1,664 | 1,672 | -108 | -6.1% | 5,900 |
2020/03/12 | 1,802 | 1,850 | 1,780 | 1,780 | -102 | -5.4% | 3,600 |
2020/03/11 | 1,800 | 1,922 | 1,800 | 1,882 | +82 | +4.6% | 1,300 |
2020/03/10 | 1,705 | 1,819 | 1,680 | 1,800 | -65 | -3.5% | 5,800 |
2020/03/09 | 1,964 | 1,964 | 1,820 | 1,865 | -127 | -6.4% | 8,800 |
2020/03/06 | 2,020 | 2,020 | 1,988 | 1,992 | -32 | -1.6% | 3,300 |
2020/03/05 | 2,039 | 2,039 | 2,024 | 2,024 | -25 | -1.2% | 1,100 |
2020/03/04 | 2,003 | 2,049 | 2,003 | 2,049 | +9 | +0.4% | 300 |
2020/03/03 | 2,055 | 2,055 | 1,980 | 2,040 | +13 | +0.6% | 2,200 |
2020/03/02 | 1,970 | 2,089 | 1,970 | 2,027 | +57 | +2.9% | 1,500 |
2020/02/28 | 2,051 | 2,051 | 1,961 | 1,970 | -110 | -5.3% | 8,500 |
2020/02/27 | 2,109 | 2,110 | 2,080 | 2,080 | -29 | -1.4% | 2,500 |
2020/02/26 | 2,126 | 2,126 | 2,109 | 2,109 | -17 | -0.8% | 500 |
2020/02/25 | 2,140 | 2,140 | 2,105 | 2,126 | -16 | -0.7% | 2,300 |
2020/02/21 | 2,150 | 2,153 | 2,132 | 2,142 | -5 | -0.2% | 2,000 |
2020/02/20 | 2,150 | 2,150 | 2,147 | 2,147 | -3 | -0.1% | 400 |
2020/02/19 | 2,130 | 2,153 | 2,130 | 2,150 | +16 | +0.7% | 1,300 |
2020/02/18 | 2,151 | 2,151 | 2,105 | 2,134 | -21 | -1% | 2,100 |
2020/02/17 | 2,166 | 2,189 | 2,155 | 2,155 | -11 | -0.5% | 2,500 |
2020/02/14 | 2,200 | 2,202 | 2,166 | 2,166 | -16 | -0.7% | 2,400 |
2020/02/13 | 2,157 | 2,240 | 2,157 | 2,182 | +5 | +0.2% | 7,800 |
2020/02/12 | 2,202 | 2,203 | 2,152 | 2,177 | +7 | +0.3% | 2,900 |
2020/02/10 | 2,168 | 2,179 | 2,155 | 2,170 | -5 | -0.2% | 3,000 |
2020/02/07 | 2,157 | 2,175 | 2,157 | 2,175 | +10 | +0.5% | 1,700 |
2020/02/06 | 2,189 | 2,189 | 2,152 | 2,165 | +3 | +0.1% | 1,300 |
2020/02/05 | 2,169 | 2,170 | 2,153 | 2,162 | +11 | +0.5% | 1,600 |
2020/02/04 | 2,194 | 2,194 | 2,151 | 2,151 | +7 | +0.3% | 1,400 |
2020/02/03 | 2,102 | 2,159 | 2,102 | 2,144 | +3 | +0.1% | 3,200 |
2020/01/31 | 2,170 | 2,170 | 2,134 | 2,141 | +21 | +1% | 2,500 |
2020/01/30 | 2,131 | 2,170 | 2,114 | 2,120 | -31 | -1.4% | 4,900 |
2020/01/29 | 2,159 | 2,189 | 2,125 | 2,151 | +29 | +1.4% | 2,400 |
2020/01/28 | 2,113 | 2,144 | 2,102 | 2,122 | -30 | -1.4% | 2,500 |
2020/01/27 | 2,182 | 2,182 | 2,103 | 2,152 | -33 | -1.5% | 5,400 |
2020/01/24 | 2,241 | 2,245 | 2,127 | 2,185 | -56 | -2.5% | 8,800 |
2020/01/23 | 2,170 | 2,250 | 2,165 | 2,241 | +80 | +3.7% | 13,000 |
2020/01/22 | 2,137 | 2,161 | 2,133 | 2,161 | +33 | +1.6% | 2,200 |
2020/01/21 | 2,130 | 2,152 | 2,125 | 2,128 | ±0 | ±0% | 4,900 |
2020/01/20 | 2,115 | 2,150 | 2,115 | 2,128 | +19 | +0.9% | 3,600 |
2020/01/17 | 2,091 | 2,109 | 2,091 | 2,109 | ±0 | ±0% | 800 |
2020/01/16 | 2,118 | 2,120 | 2,086 | 2,109 | -6 | -0.3% | 2,500 |
2020/01/15 | 2,070 | 2,115 | 2,070 | 2,115 | +45 | +2.2% | 2,800 |
1251~
1300
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
仁 丹 | 208,400円 | +2.4% | +10.4% | 2.64% | 12.18倍 | 0.68倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
カイオム | 13,800円 | +92.3% | - | 0.00% | - | 4.92倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
PRISMBio | 23,600円 | +14.8% | - | 0.00% | - | 2.47倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
ケイファーマ | 74,300円 | - | - | 0.00% | - | 3.82倍 |
|
慶応大学発ベンチャー。iPS細胞による再生医療と創薬の2本柱。中枢神経系が得意領域 |
サイフューズ | 97,200円 | +459.3% | - | 0.00% | - | 3.24倍 |
|
バイオ3Dプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
市場注目の銘柄
チャート関連のコラム